Risk factors for small bowel bleeding in an overt gastrointestinal bleeding presentation after negative upper and lower endoscopy.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 28 10 2018
accepted: 23 01 2019
entrez: 21 2 2019
pubmed: 21 2 2019
medline: 18 12 2019
Statut: epublish

Résumé

A small bowel source is suspected when evaluation of overt gastrointestinal (GI) bleeding with upper and lower endoscopy is negative. Video capsule endoscopy (VCE) is the recommended next diagnostic test for small bowel bleeding sources. However, clinical or endoscopic predictive factors for small bowel bleeding in the setting of an overt bleeding presentation are unknown. We aimed to define predictive factors for positive VCE among individuals presenting with overt bleeding and a suspected small bowel source. We included consecutive inpatient VCE performed between September 1, 2012 to September 1, 2015 for melena or hematochezia at two tertiary centers. All patients had EGD and colonoscopy performed prior to VCE. Patient demographics, medication use, and endoscopic findings were retrospectively recorded. VCE findings were graded based on the P0-P2 grading system. The primary outcome of interest was a positive (P2) VCE. The secondary outcome of interest was the performance of a therapeutic intervention. Data were analyzed with the Fisher exact test for dichotomous variables and logistic regression. Two hundred forty-three VCE were reviewed, and 117 were included in the final analysis. A positive VCE (P2) was identified in 35 (29.9%) cases. In univariate analysis, a positive VCE was inversely associated with presence of diverticula on preceding colonoscopy (OR: 0.44, 95% CI: 0.2-0.99), while identification of blood on terminal ileal examination was associated with a positive VCE (OR: 5.18, 95% CI: 1.51-17.76). In multivariate analysis, only blood identified on terminal ileal examination remained a significant risk factor for positive VCE (OR: 6.13, 95% CI: 1.57-23.81). Blood on terminal ileal examination was also predictive of therapeutic intervention in both univariate (OR: 4.46, 95% CI: 1.3-15.2) and multivariate analysis (OR: 5.04, 95% CI: 1.25-20.32). Among patients presenting with overt bleeding but negative upper and lower endoscopy, the presence of blood on examination of the terminal ileum is strongly associated with a small bowel bleeding source as well as with small bowel therapeutic intervention. Presence of diverticula on colonoscopy is inversely associated with a positive VCE and therapeutic intervention in univariate analysis.

Identifiants

pubmed: 30785946
doi: 10.1371/journal.pone.0212509
pii: PONE-D-18-30528
pmc: PMC6382158
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0212509

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Hippokratia. 2016 Apr-Jun;20(2):127-132
pubmed: 28416909
Am J Gastroenterol. 1997 Mar;92(3):419-24
pubmed: 9068461
Dig Dis Sci. 2011 Apr;56(4):1188-93
pubmed: 20859686
Gastrointest Endosc. 2013 May;77(5):761-6
pubmed: 23375526
Gastrointest Endosc. 2003 Sep;58(3):330-5
pubmed: 14528203
Am J Gastroenterol. 2016 Apr;111(4):459-74
pubmed: 26925883
Gastrointest Endosc. 2004 Dec;60(6):959-64
pubmed: 15605012
Med Care. 2005 Nov;43(11):1130-9
pubmed: 16224307
Am J Gastroenterol. 2015 Sep;110(9):1265-87; quiz 1288
pubmed: 26303132
Gastrointest Endosc. 2015 Apr;81(4):889-95
pubmed: 25432532
Clin Gastroenterol Hepatol. 2013 Oct;11(10):1224-31
pubmed: 23524277
Gastroenterology. 2004 Mar;126(3):643-53
pubmed: 14988816
Clin Gastroenterol Hepatol. 2012 Dec;10(12):1376-80
pubmed: 22677574
Endoscopy. 2003 Jul;35(7):576-84
pubmed: 12822092
Gastrointest Endosc. 1999 Feb;49(2):228-38
pubmed: 9925703
J Clin Epidemiol. 1992 Jun;45(6):613-9
pubmed: 1607900
N Engl J Med. 2000 Jan 13;342(2):78-82
pubmed: 10631275
Gastrointest Endosc. 2011 Nov;74(5):1061-6
pubmed: 21924720

Auteurs

Dejan Micic (D)

University of Chicago Medicine, Department of Internal Medicine, Section of Gastroenterology, Hepatology and Nutrition, Chicago, IL,United States of America.

John N Gaetano (JN)

University of Chicago Medicine, Department of Internal Medicine, Section of Gastroenterology, Hepatology and Nutrition, Chicago, IL,United States of America.

Neha Nigam (N)

University of Chicago Medicine, Department of Internal Medicine, Section of Gastroenterology, Hepatology and Nutrition, Chicago, IL,United States of America.

Matthew Peller (M)

Northwestern Medicine, Department of Internal Medicine, Chicago, IL, United States of America.

Vijaya L Rao (VL)

University of Chicago Medicine, Department of Internal Medicine, Section of Gastroenterology, Hepatology and Nutrition, Chicago, IL,United States of America.

Carol Semrad (C)

University of Chicago Medicine, Department of Internal Medicine, Section of Gastroenterology, Hepatology and Nutrition, Chicago, IL,United States of America.

Adam C Stein (AC)

Northwestern Medicine, Department of Internal Medicine, Division of Gastroenterology and Hepatology, Chicago, IL, United States of America.

Sonia S Kupfer (SS)

University of Chicago Medicine, Department of Internal Medicine, Section of Gastroenterology, Hepatology and Nutrition, Chicago, IL,United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH